Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced- calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available […] The post FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions appeared first on Web-Release.

    Aster DM Healthcare Limited today announced that it has received an overwhelming 96.68% voting approval from shareholders along with a significant majority of minority shareholders and creditors voting in favour of the proposed Scheme of Amalgamation with Quality Care India Limited (QCIL). The approval follows support from the Company’s shareholders, in favour of the share swap preceding the […] The post Aster DM Healthcare receives overwhelmingly positive shareholder and creditors vote for Aster-QCIL merger appeared first on Web-Release.